TEDESCHI, SARA
 Distribuzione geografica
Continente #
AS - Asia 5.954
NA - Nord America 5.675
EU - Europa 4.615
SA - Sud America 399
Continente sconosciuto - Info sul continente non disponibili 347
AF - Africa 268
OC - Oceania 19
Totale 17.277
Nazione #
US - Stati Uniti d'America 5.539
CN - Cina 1.668
SG - Singapore 1.624
IT - Italia 1.298
VN - Vietnam 1.215
DE - Germania 731
GB - Regno Unito 571
NL - Olanda 498
SE - Svezia 419
HK - Hong Kong 335
BR - Brasile 278
KR - Corea 274
IN - India 244
FR - Francia 229
RU - Federazione Russa 181
BD - Bangladesh 178
IE - Irlanda 137
JP - Giappone 113
FI - Finlandia 111
CI - Costa d'Avorio 89
BG - Bulgaria 75
CA - Canada 66
ZA - Sudafrica 58
CH - Svizzera 54
AR - Argentina 50
ES - Italia 50
AT - Austria 46
UA - Ucraina 43
JO - Giordania 42
ID - Indonesia 39
BE - Belgio 36
EE - Estonia 36
TG - Togo 35
PH - Filippine 31
IQ - Iraq 28
MX - Messico 28
NG - Nigeria 27
TR - Turchia 24
TH - Thailandia 23
PK - Pakistan 20
PL - Polonia 20
SC - Seychelles 17
TW - Taiwan 17
AU - Australia 16
EC - Ecuador 15
CO - Colombia 14
RO - Romania 13
CL - Cile 12
SA - Arabia Saudita 12
LT - Lituania 11
MY - Malesia 10
UZ - Uzbekistan 10
PT - Portogallo 9
PE - Perù 8
CZ - Repubblica Ceca 7
TN - Tunisia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HR - Croazia 6
IR - Iran 6
KE - Kenya 6
UY - Uruguay 6
CR - Costa Rica 5
EG - Egitto 5
JM - Giamaica 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
AL - Albania 4
AZ - Azerbaigian 4
CY - Cipro 4
DZ - Algeria 4
LY - Libia 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
LV - Lettonia 3
MA - Marocco 3
NI - Nicaragua 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
GP - Guadalupe 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SM - San Marino 2
Totale 16.901
Città #
Singapore 1.159
Ashburn 687
Hefei 558
Southend 456
Fairfield 435
Frankfurt am Main 379
San Jose 339
Eygelshoven 338
Chandler 321
Hong Kong 317
Ho Chi Minh City 309
Hanoi 254
Seoul 250
Bologna 245
Santa Clara 223
Wilmington 203
Woodbridge 198
Ann Arbor 196
Beijing 178
Houston 171
Seattle 168
New York 163
Boardman 150
Cambridge 147
Dublin 136
Princeton 129
Milan 125
Dong Ket 101
Los Angeles 98
Lauterbourg 95
Tokyo 93
Abidjan 89
Helsinki 83
Dallas 78
Rome 74
Council Bluffs 73
Sofia 71
Bengaluru 56
Buffalo 55
Chicago 51
São Paulo 46
Nanjing 44
Westminster 43
Da Nang 42
Haiphong 42
Amman 41
Berlin 39
Bern 39
Padova 37
Munich 36
Redondo Beach 36
Saint Petersburg 36
Lomé 35
Turin 34
Vienna 32
Amsterdam 31
Jinan 31
Shanghai 31
Brussels 30
San Diego 30
Redmond 29
Bremen 28
Falls Church 27
Guangzhou 27
Nuremberg 27
Jakarta 25
London 25
Modena 25
Abeokuta 21
Florence 20
Orem 20
Shenyang 20
Toronto 20
Changsha 19
Montreal 19
San Francisco 19
Naples 18
Redwood City 18
Washington 18
Hebei 17
Nanchang 17
Parma 17
Denver 16
Hải Dương 16
Lappeenranta 16
Tongling 16
Atlanta 15
Brooklyn 15
Dearborn 15
Des Moines 15
Mexico City 15
Thái Nguyên 15
Zhengzhou 15
Genoa 14
Hangzhou 14
Phoenix 14
Rio de Janeiro 14
Warsaw 14
Yubileyny 14
Biên Hòa 13
Totale 10.728
Nome #
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 940
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 322
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 257
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 254
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 253
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 242
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study 239
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 232
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 226
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 225
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 225
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 222
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 219
Bone and Joint Infections: The Role of Imaging in Tailoring Diagnosis to Improve Patients' Care 219
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 217
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 215
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 213
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 205
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 202
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 202
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 196
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 195
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 191
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 191
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 187
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 184
Multidisciplinary treatment protocol for ischiatic, sacral, trochanteric or other pressure injuries in people with spinal cord injury: a retrospective cohort study 182
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections? 182
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 181
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 179
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections 177
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
In the search for appropriateness in the cure of vaginitis: a model of anti-fungal stewardship? 176
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 176
Epidemiology of Fungal Periprosthetic Joint Infection: A Systematic Review of the Literature 175
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 173
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 172
Effective Containment of a COVID-19 Subregional Outbreak in Italy through Strict Quarantine and Rearrangement of Local Health Care Services 172
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 171
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 168
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 167
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 167
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 167
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 166
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 166
Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series 164
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections 164
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 164
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 162
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 162
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 161
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 160
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 152
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 150
Combined Orthoplastic Approach in Fracture-Related Infections of the Distal Tibia 149
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 147
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 145
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 144
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 143
A local outbreak as mirror-like scenario for COVID-19 worldwide progression. Clinical presentation to the Emergency Department during one of the first sub-regional outbreak in Italy A lesson to learn 140
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients. 138
Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter study 137
Multiple Flaps for Trochanteric Pressure Sore Reconstruction: A Case Series 133
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort 133
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 133
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 131
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 128
GPT-based chatbot tools are still unreliable in the management of prosthetic joint infections 126
Opportunistic infections in end stage liver disease 126
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 126
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 125
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring 124
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 123
Individualizing duration of antibiotic therapy in community-acquired pneumonia 122
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 121
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 120
An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic 116
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 115
"MRI, culture of swab specimen and two stage surgery in spinal cord injury patients with pressure sores" 114
Synchronous Periprosthetic Joint Infections: A Scoping Review of the Literature 114
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 114
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 112
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 111
Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review 108
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 104
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis 104
Obesity Is One of the Strongest Risk Factor for Respiratory Failure and Death in COVID-19 Patients: A Retrospective Multicentric Cohort Study 102
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group 98
The Need for Multidisciplinarity in Modern Medicine: An Insight into Orthopaedic Infections 95
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study 94
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study 94
The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus 94
null 91
null 90
Osteomyelitis of the pelvic bones in patients with spinal cord injury: Is magnetic resonance useful for preoperative diagnosis? 89
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" 86
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 86
null 77
Totale 16.720
Categoria #
all - tutte 47.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.332 0 56 65 144 121 77 80 100 77 157 257 198
2022/20231.603 123 177 87 219 147 118 60 113 294 68 112 85
2023/2024897 70 90 54 105 76 194 63 58 33 72 36 46
2024/20252.709 112 247 214 214 313 149 196 93 58 244 263 606
2025/20267.568 718 857 649 567 639 664 947 183 1.178 520 302 344
2026/2027426 221 205 0 0 0 0 0 0 0 0 0 0
Totale 17.277